The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling

The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling

IntroductionIt is unknown whether alteplase is effective and safe in patients with mild acute ischemic stroke (AIS). Determining whether symptoms are “disabling” or not is a crucial factor in the management of these patients. This study aimed to investigate the efficacy and safety of alteplase in pa...

Full description

Bibliographic Details
Main Authors: Giovanni Merlino, Lorenzo Nesi, Pietro Vergobbi, Marco Domenico Scanni, Sara Pez, Alessandro Marziali, Yan Tereshko, Giuseppe Sportelli, Simone Lorenzut, Francesco Janes, Gian Luigi Gigli, Mariarosaria Valente
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Neurology
Subjects:
mild stroke
non-disabling stroke
alteplase
intravenous thrombolysis
NIHSS
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1212712/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1212712/full

Similar Items